MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Hypothyroidism is a condition that affects the functioning of a patient’s thyroid gland. It can cause the thyroid gland to produce an inadequate amount of thyroid hormone, leading to a wide range of symptoms all over the body. Stem cell therapy is now being considered
R3 Stem Cell Mexico is now offering a complimentary PRP with each booked stem cell procedure. The platelet rich plasma therapy may be used for an extremity or soft tissue injection either alone or in conjunction with a stem cell therapy. As the most cost-effective provider of
R3 Stem Cell Mexico is now offering treatment with 150 billion exosomes for only $13,550. The treatments are available in both of R3’s Mexico locations including Tijuana and Cancun. They have been a revolutionary treatment option for patients who have either failed conventional therapy, or
R3 Stem Cell announced today that the company has achieved IRB Approval for its regenerative study titled, “Safety and Clinical Outcomes Study: Amniotic and Umbilical Cord Tissue Administration for Orthopedic, Neurologic, Urologic, Autoimmune, Cardiac, Renal and Pulmonary Conditions”. The company will be acquiring data for
Sickle cell disease is a condition that affects the shape of red blood cells. It can make these cells misshapen and damage their ability to carry oxygen to other organs of the body. Stem cell therapy is currently the only method known to help patients
R3 Medical Training announced today that it has achieved CME Accreditation for its Medical Aesthetics Training Course for both medical and dental professionals. R3 Medical Training announced today that it has achieved CME Accreditation for its Medical Aesthetics Training Course for both medical and dental professionals.
Tourette syndrome is commonly thought to be associated with the uncontrollable urge to say swear words, but that is not the case. This condition affects the nervous system and control of our bodies. Some people with the condition may have symptoms like uncontrollable tapping or
Cancer of any form can be extremely frightening. Intestinal cancer can affect your small intestine and large intestine and cause chronic pain. Your intestinal tract may be blocked by a tumor, which can lead to a food bolus forming. This blockage is what causes chronic
Stem cell therapy has been thought about as an effective solution for various diseases, with the prevalent condition being regenerative disorders. However, stem cells can also treat some other illnesses that are entirely unrelated to regenerative disorders. Take chronic migraines, for instance; an effective cure
Regenerative medicine refers to therapies that are able to repair, restore and regenerate damaged tissues in the body. These therapies represent a significant advancement from traditional ones that only offer symptom relief as a proverbial ‘band-aid’. The revolutionary treatments have been in the limelight in
